NCT03695198View on ClinicalTrials.gov

A Study of LY3361237 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 26, 2018

Primary Completion Date

August 29, 2019

Study Completion Date

August 29, 2019

Conditions
Healthy
Interventions
DRUG

LY3361237 - SC

LY3361237 administered SC

DRUG

LY3361237 - IV

LY3361237 administered IV

DRUG

Placebo - SC

Placebo administered SC

DRUG

Placebo - IV

Placebo administered IV

Trial Locations (1)

91206

California Clinical Trials Medical Group, Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03695198 - A Study of LY3361237 in Healthy Participants | Biotech Hunter | Biotech Hunter